Health Technology Holding (HTH)

Italy
HTH is an investment and advisory firm investing in health-focused innovators since 2016. They work closely with pharma companies to fund life science ventures, provide corporate innovation capabilities, and open stakeholder networks. Their science-first approach involves deep due diligence, including data, models, and clinical expert interviews, typically completed within 1-2 months.

Fund scope

Investment criteria breakdown.
Investment stages
Pre-Seed
Seed
Series A
Series B+
Target regions
USA
Canada
Europe
Israel
Investment ranges
$500K - $1M
Focus areas
Biotech
Deeptech
Health

Related unicorns

A glimpse at some of the $1B+ valuation companies backed by this fund.

Partners

Fund leadership and team.
Marco Gullà
Investment Associate
View profile
Michelle Gaiotto
Managing Partner
View profile

Related Sector Funds

Funds investing in similar industries.
.406 Ventures Fund
Boston, Massachusetts
Seed
Series A
Series B+
+ND Capital Fund)
Cayman Islands
Seed
Series A
Series B+
11.2 Capital
San Francisco, California
Pre-Seed
Seed
Series A
Series B+
1955 Capital
San Francisco, California
Pre-Seed
Seed
1984 Ventures
Los Altos, California
Series A
Series B+
1kx
San Francisco, California
Pre-Seed
Seed

Browse more categories